SB331

Senate Bill 331, titled the 'Genetic Testing Act,' requires health benefit plans in Arkansas to provide coverage for clinical genetic testing for inherited cancer mutations and evidence-based cancer imaging for enrollees deemed to have an increased risk of cancer. To qualify, testing and imaging must be recommended by a healthcare professional according to established clinical practice guidelines. The bill stipulates that this coverage cannot be subject to cost-sharing requirements, such as deductibles or copayments, except where such requirements would interfere with health savings account ineligibility under federal law. The provisions are set to take effect on January 1, 2026. The bill explicitly excludes certain insurance types, such as Medicaid, workers' compensation, and state-employee plans, from these mandates. The Insurance Commissioner is authorized to develop rules for the act's implementation.